Intas Pharmaceuticals Ltd:企業の戦略的SWOT分析

◆英語タイトル:Intas Pharmaceuticals Ltd - Strategic SWOT Analysis Review
◆商品コード:GDPH91416SA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Intas Pharmaceuticals Ltd – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Intas Pharmaceuticals Ltd (Intas) develops, manufactures, and markets pharmaceuticals and biotechnology products for the treatment of a wide range of diseases and disorders in various therapeutic segments. The company offers products such as sevelamer, ciprofloxacin, amitryptyline, erythropoietin, filgrastim, follicle stimulating hormone (FSH), rituximab, ampicillin, albendazole, benezepril, and caprofen, among others. It also develops recombinant DNA protein (rDNA) products and plasma derived products for oncology, auto-immune, ophthalmology, nephrology and plasma derived product based therapies. It has formulation manufacturing facilities and active pharmaceutical ingredient (API) and intermediate facilities in India. The company markets products through internal sales force and a network of distributors worldwide. Intas is headquartered in Ahmedabad, Gujarat, India.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Intas Pharmaceuticals Ltd – Key Facts
Intas Pharmaceuticals Ltd – Key Employees
Intas Pharmaceuticals Ltd – Major Products and Services
Intas Pharmaceuticals Ltd – History
Intas Pharmaceuticals Ltd – Company Statement
Intas Pharmaceuticals Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Intas Pharmaceuticals Ltd – Business Description
Intas Pharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
Intas Pharmaceuticals Ltd – Strengths
Intas Pharmaceuticals Ltd – Weaknesses
Intas Pharmaceuticals Ltd – Opportunities
Intas Pharmaceuticals Ltd – Threats
Intas Pharmaceuticals Ltd – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Intas Pharmaceuticals Ltd, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Intas Pharmaceuticals Ltd, Key Facts
Intas Pharmaceuticals Ltd, Key Employees
Intas Pharmaceuticals Ltd, Major Products and Services
Intas Pharmaceuticals Ltd, History
Intas Pharmaceuticals Ltd, Other Locations
Intas Pharmaceuticals Ltd, Subsidiaries
Intas Pharmaceuticals Ltd, Key Competitors
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Intas Pharmaceuticals Ltd, Recent Deals Summary

★海外企業調査レポート[Intas Pharmaceuticals Ltd:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Emmis Communications Corporation (EMMS):企業の財務・戦略的SWOT分析
    Emmis Communications Corporation (EMMS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • QNB Finansbank (FINBN):企業の財務・戦略的SWOT分析
    QNB Finansbank (FINBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Business Connexion Group Limited:企業の戦略的SWOT分析
    Business Connexion Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Tokyo Electric Power Company Holdings Incorporated (9501)-エネルギー分野:企業M&A・提携分析
    Summary Tokyo Electric Power Company Holdings, Incorporated (TEPCO), formerly Tokyo Electric Power Company, Incorporated, is an integrated energy company. The company generates, transmits, distributes and sells electricity through its subsidiaries. It generates power from various sources such as the …
  • Sermonix Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Sermonix Pharmaceuticals LLC (Sermonix) is a biotechnology company develops female-specific oncology products. The company provides lead product such as lasofoxifene, which is a selective estrogen receptor modulator. Its lasofoxifene is used in the treatment of common disorders affecting wom …
  • Europa Oil & Gas (Holdings) Plc (EOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Europa Oil & Gas (Holdings) Plc (Europa Oil) is an oil and gas company that offers exploration and development services. The company's services include production and development of conventional and unconventional hydrocarbon assets. It operates its assets in East Midlands basin, Aquitain ba …
  • Windflow Technology Ltd (WTL):企業の財務・戦略的SWOT分析
    Windflow Technology Ltd (WTL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Bayer CropScience AG:企業のM&A・事業提携・投資動向
    Bayer CropScience AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bayer CropScience AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • KFG Resources Ltd (KFG):企業の財務・戦略的SWOT分析
    Summary KFG Resources Ltd (KFG) is a petroleum and natural gas exploration company that supplies natural gas. The company produces crude oil and natural gas through its reserves. Its oil and gas reserves are located in Mississippi, Wilcox, and Louisiana. KFG’s Mississippi’s projects comprise Carthag …
  • Hachsharat Hayishuv Hotels Ltd.:企業の戦略・SWOT・財務分析
    Hachsharat Hayishuv Hotels Ltd. - Strategy, SWOT and Corporate Finance Report Summary Hachsharat Hayishuv Hotels Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Washington University School of Medicine-製薬・医療分野:企業M&A・提携分析
    Summary Washington University School of Medicine (WUSTL), a subsidiary of University of Washington is a medical university that offers patient care, research, education services and neurology clinical trials. The university provides patient care services such as clinical, find a doctor, referring ph …
  • AB Electrolux:企業の戦略・SWOT・財務情報
    AB Electrolux - Strategy, SWOT and Corporate Finance Report Summary AB Electrolux - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Fresenius Kabi AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Fresenius Kabi AG (Fresenius Kabi), a wholly owned subsidiary of Fresenius SE & Co KGaA, develops, manufactures and markets pharmaceuticals products and medical devices. The company's product portfolio includes intravenously administered drugs, infusion therapy products, medical devices and …
  • Pilgrim’s Pride Corporation:企業の戦略・SWOT・財務情報
    Pilgrim's Pride Corporation - Strategy, SWOT and Corporate Finance Report Summary Pilgrim's Pride Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Neurones SA (NRO):企業の財務・戦略的SWOT分析
    Neurones SA (NRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Armstrong World Industries Inc (AWI):企業の財務・戦略的SWOT分析
    Armstrong World Industries Inc (AWI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • DormaKaba Holding AG:企業の戦略・SWOT・財務情報
    DormaKaba Holding AG - Strategy, SWOT and Corporate Finance Report Summary DormaKaba Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • CymaBay Therapeutics Inc (CBAY):企業の財務・戦略的SWOT分析
    CymaBay Therapeutics Inc (CBAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Amoy Diagnostics Co Ltd (300685):医療機器:M&Aディール及び事業提携情報
    Summary Amoy Diagnostics Co Ltd (AmoyDx) is a developer of molecular diagnostics for oncology precision medicine. The company provides gene mutation products such as mutation detection kit and gene fusions detection kit. It offers nucleic acid extraction products including DNA and RNA extraction kit …
  • Caixa Economica Federal
    Caixa Economica Federal - Strategy, SWOT and Corporate Finance Report Summary Caixa Economica Federal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆